Neuropathologic differences by race from the National Alzheimer's Coordinating Center.
Neuropathologic differences by race from the National Alzheimer's Coordinating Center.
复制标题
DOI:
10.1016/j.jalz.2016.03.004
复制
发表时间:
2016-06
期刊:
影响因子:
--
通讯作者:
Dickson DW
中科院分区:
文献类型:
--
作者:
Graff-Radford NR;Besser LM;Crook JE;Kukull WA;Dickson DW
Compared to Caucasians, African Americans (AA) have higher dementia prevalence, different genetic markers and higher vascular risk factors. However, pathological underpinnings are unknown. We used neuropathological and clinical data on 110 AA and 2500 Caucasians who were demented before death. The groups were compared regarding demographics, cognition, apolipoprotein E (ApoE) genotype, comorbidities, and clinical and neuropathological characteristics. AA and Caucasians differed in their demographics, cognition at the last visit before death, ApoE genotype, presence of hypertension, primary clinical diagnoses, and AD, cerebrovascular disease (CVD), and other neuropathologies such as Lewy body disease (LBD). AD, LBD and CVD pathology were more common and TDP and FTLD-tau less common in AA than in Caucasians. ApoE accounted for most of the AD neuropathological differences. If replicated, the observed differences in underlying neuropathology by race will be important for public health policy, and recruitment for and interpreting of clinical trials.